BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 15491974)

  • 41. Lack of apoptosis of Sézary cells in the circulation following oral bexarotene therapy.
    Brennand S; Sutton VR; Biagi J; Trapani JA; Westerman D; McCormack CJ; Seymour JF; Kennedy G; Prince HM
    Br J Dermatol; 2005 Jun; 152(6):1199-205. PubMed ID: 15948982
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CXCL13 is highly produced by Sézary cells and enhances their migratory ability via a synergistic mechanism involving CCL19 and CCL21 chemokines.
    Picchio MC; Scala E; Pomponi D; Caprini E; Frontani M; Angelucci I; Mangoni A; Lazzeri C; Perez M; Remotti D; Bonoldi E; Benucci R; Baliva G; Lombardo GA; Napolitano M; Russo G; Narducci MG
    Cancer Res; 2008 Sep; 68(17):7137-46. PubMed ID: 18757429
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Flow cytometric determination of ploidy and proliferative activity on isolated bone marrow particles and on total bone marrow aspirate.
    Ucci G; Mazzini G; Caporali R; Danova M; Montecucco CM; Riccardi A
    Basic Appl Histochem; 1987; 31(1):83-90. PubMed ID: 3593175
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heterogeneity of circulating CD4+ memory T-cell subsets in erythrodermic patients: CD27 analysis can help to distinguish cutaneous T-cell lymphomas from inflammatory erythroderma.
    Fierro MT; Novelli M; Quaglino P; Comessatti A; Fava P; Ortoncelli M; Ponti R; Bernengo MG
    Dermatology; 2008; 216(3):213-21. PubMed ID: 18182812
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytogenetic abnormalities in patients with cutaneous T-cell lymphomas.
    Whang-Peng J; Bunn P; Knutsen T; Schechter GP; Gazdar AF; Matthews MJ; Minna JD
    Cancer Treat Rep; 1979 Apr; 63(4):575-80. PubMed ID: 312695
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD20+ T-cell lymphoma: clinicopathologic analysis of 9 cases and a review of the literature.
    Rahemtullah A; Longtine JA; Harris NL; Dorn M; Zembowicz A; Quintanilla-Fend L; Preffer FI; Ferry JA
    Am J Surg Pathol; 2008 Nov; 32(11):1593-607. PubMed ID: 18753947
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
    Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
    Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relations of proliferative activities of gastric carcinoma cells to lymphatic involvement, venous invasion and prognosis.
    Wu YF; Xu HM; Chen JQ
    Chin Med J (Engl); 2004 Oct; 117(10):1530-5. PubMed ID: 15498378
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Total skin electron beam therapy may be associated with improvement of peripheral blood disease in Sézary syndrome.
    Introcaso CE; Micaily B; Richardson SK; Junkins-Hopkins JM; Yoon JS; Kim EJ; Vittorio CC; Rook AH
    J Am Acad Dermatol; 2008 Apr; 58(4):592-5. PubMed ID: 18249469
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Single TCR-Vβ2 evaluation discloses the circulating T cell clone in Sezary syndrome: one family fits all!
    Scala E; Abeni D; Pomponi D; Russo N; Russo G; Narducci MG
    Arch Dermatol Res; 2015 Aug; 307(6):487-93. PubMed ID: 25733488
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DNA ploidy analysis as an adjunct for the detection of relapse in B-lineage acute lymphoblastic leukemia.
    Kenney B; Zieske A; Rinder H; Smith B
    Leuk Lymphoma; 2008 Jan; 49(1):42-8. PubMed ID: 18203010
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytologic transformation in cutaneous T cell lymphoma: a clinicopathologic entity associated with poor prognosis.
    Dmitrovsky E; Matthews MJ; Bunn PA; Schechter GP; Makuch RW; Winkler CF; Eddy J; Sausville EA; Ihde DC
    J Clin Oncol; 1987 Feb; 5(2):208-15. PubMed ID: 3492594
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aberrant phenotypes and quantitative antigen expression in different subtypes of canine lymphoma by flow cytometry.
    Gelain ME; Mazzilli M; Riondato F; Marconato L; Comazzi S
    Vet Immunol Immunopathol; 2008 Feb; 121(3-4):179-88. PubMed ID: 17981339
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low proliferative activity is associated with a favorable prognosis in peripheral T-cell lymphoma.
    Grierson HL; Wooldridge TN; Purtilo DT; Pierson J; Bast M; Wooldridge L; Armitage JO; Weisenburger DD
    Cancer Res; 1990 Aug; 50(16):4845-8. PubMed ID: 2379148
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Absence of CD26 expression on skin-homing CLA+ CD4+ T lymphocytes in peripheral blood is a highly sensitive marker for early diagnosis and therapeutic monitoring of patients with Sézary syndrome.
    Sokolowska-Wojdylo M; Wenzel J; Gaffal E; Steitz J; Roszkiewicz J; Bieber T; Tüting T
    Clin Exp Dermatol; 2005 Nov; 30(6):702-6. PubMed ID: 16197392
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral bexarotene in a therapy-resistant Sézary syndrome patient: observations on Sézary cell compartmentalization.
    el-Azhary RA; Bouwhuis SA
    Int J Dermatol; 2005 Jan; 44(1):25-8. PubMed ID: 15663654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Problems in DNA ploidy analysis using flow cytometry--influences from contaminant mononuclear cells].
    Yasuda N; Fukushima T; Saito Y; Nakai S; Murakami Y; Matsumoto H
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):726-30. PubMed ID: 8489275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.